Skip to main navigation
Liquidia Logo
Skip to main content
Liquidia Logo

    Home

  • Home
  • About

  • About Liquidia
    • Overview
    • Leadership
    • Board of Directors
  • Products and Pipeline

  • Pipeline and Products
    • Pipeline
    • Commercial Products
    • PRINT® Technology
    • Publications
  • IR Nav

  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Analyst Coverage
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Corporate Governance
      • Documents & Charters
      • Leadership
      • Board of Directors
      • Committee Composition
    • SEC Filings
    • IR Resources
      • Investor FAQs
      • IR Contact
      • Email Alerts
      • Proxy Online
  • Careers

  • Careers
    • Overview
    • Jobs
    • Benefits
    • Principles
  • Contact Us

  • Contact Us
    • Overview
    • Map/Directions

SEC Filings

IR Nav

Investors
  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
    Analyst Coverage Stock Quote & Chart Historical Price Lookup Investment Calculator
  • Corporate Governance
    Documents & Charters Leadership Board of Directors Committee Composition
  • SEC Filings
  • IR Resources
    Investor FAQs IR Contact Email Alerts Proxy Online

SEC Filings

Filing date Form Description Filing Group View
Feb 20, 2018 D
Other
0001330436-18-000001.pdf
0001330436-18-000001.rtf
Jan 07, 2020 D
Other
0001330436-20-000001.pdf
0001330436-20-000001.rtf
Apr 16, 2021 D
Other
0001819576-21-000001.pdf
0001819576-21-000001.rtf
0001819576-21-000001.xls
Jul 15, 2009 D
Other
0001330436-09-000005.pdf
0001330436-09-000005.rtf
0001330436-09-000005.xls
Jan 21, 2010 D/A
Other
0001330436-10-000001.pdf
0001330436-10-000001.rtf
0001330436-10-000001.xls
May 25, 2010 D/A
Other
0001330436-10-000002.pdf
0001330436-10-000002.rtf
0001330436-10-000002.xls
Mar 03, 2011 D
Other
0001330436-11-000001.pdf
0001330436-11-000001.rtf
0001330436-11-000001.xls
Jul 02, 2012 D/A
Other
0001330436-12-000001.pdf
0001330436-12-000001.rtf
0001330436-12-000001.xls
Nov 18, 2020 25-NSE

25-NSE

Other
0001354457-20-000714.pdf
0001354457-20-000714.rtf
0001354457-20-000714.xls
Feb 02, 2021 8-K12B/A

8-K12B/A

Other
0001104659-21-010896.pdf
0001104659-21-010896.rtf
0001104659-21-010896.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page ›
  • Last page »
Displaying 1 - 10 of 488 results

Data provided by Kaleidoscope.

IR Tools

  • Print Page
  • Share
  • RSS
Liquidia Logo

419 Davis Drive, Suite 100, Morrisville, NC 27560
Tel +1 919-328-4400
Fax +1 919-328-4402

Socials

© 2023 Liquidia Corporation All Rights Reserved.

Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH). Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as generic Treprostinil Injection.

Legal Nav

  • Legal
  • Privacy
  • Cookies
  • Social Media
  • Facebook
  • Twitter
  • LinkedIn